Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers

A new orodispersible film formulation of the phosphodiesterase type 5 inhibitor, sildenafil, has been developed to examine the advantages of an orally disintegrating film formulation and provide an alternative to the current marketed products for the treatment of erectile dysfunction. The pharmacoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Radicioni, Milko, Castiglioni, Chiara, Giori, Andrea, Cupone, Irma, Frangione, Valeria, Rovati, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395281/
https://www.ncbi.nlm.nih.gov/pubmed/28442892
http://dx.doi.org/10.2147/DDDT.S124034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395281/
https://www.ncbi.nlm.nih.gov/pubmed/28442892
http://dx.doi.org/10.2147/DDDT.S124034

Ejemplares similares